共 13 条
[1]
DifferentialvasorelaxanteffectsofK+-channelopenersandCa2+-channelblockersoncanineisolatedarteries. IIwamotoT,NishimuraN,MoritaT,etal. JPharmPharmacolSuppl . 1993
[2]
The effects of a novel Ca 2 + channel blocker, KB-2796, on 5-HTinduced response. Fuj ishima Y, Hara H, Shimazawa M, et al. Ni ppon Yakuri gaku Zasshi . 1994
[3]
protectiveeffectofKB -2796,anewcalciumantagonist,incerebralhy poxiaandischemia. HaraH,OzakiA,YoshidomiM,etal. ArchIntPharmacodynTher . 1990
[4]
Metabolism of lomerizine hydrochloride in human. Awata N, Kawashima T, Sakai T. Jpn Pharmacol Th_er . 1994
[5]
Effects of the neuroprotective agent, KB-2796, on the voltage-dependent sodium current in mouse neuroblastoma, N1E115. Givern JGM, Patmore L, Sheridan RD. Rd Proc Br Pharmacol Soc . 1994
[6]
Isolation and identification of the new metabolites of 1—[bis（ 4—fluorophenyl） —methyl] —4— （ 2, 3, 4—trimethboxybenzyl） pi perazine dihydrochloride（KB - 2796 ） from rat bile, urine and feces. Kawashim T, Satomi O, Awata N, et al. Journal of Pharmacobio Dynamics . 1991
[7]
Longtermtrialoflomerizinehydrochlorideformigraine. GotohF,FukuuchiY,TashiroK,etal. JpnPhar_macolTher . 1995
[8]
Clinical evaluation of lomerizine hydrochloride（KB-2796）for cluster headache. Gotoh F, Fukuuchi Y, Tashiro K, et al. Japanese Pharmacology and Therapeutics . 1995
[9]
Selectiveef fectofKB-2796,anewcalciumentryblocker,oncer bralcirculation:acomparativestudyoftheeffectsofcalciumentry blockersoncerebraland peripheralar terialbloodflows. KanazawaT,MoritaT,HaradaK,etal. JCardiovascPharmacol . 1990
[10]
Clinical effect of KB-2796 on migraine-early phase Ⅱstudy. Gotoh F,Tashiro K,Kutsuzawa N,et al. Japanese Pharmacology and Therapeutics . 1994